Informational Only · Not Medical Advice · Consult a Dermatologist · Editorial Policy

Recovery and Pigment Safety in the 2026 Split-Face Acne Scar Trial: Who Was Studied and Who Was Not for People With Icepick Acne Scars

The 2026 split-face trial tested recovery and pigment safety in 24 Asian adults with moderate-to-severe atrophic acne scars with Fitzpatrick skin types III to V. People with mainly icepick scars, very fair or very dark skin, active acne, keloid history, recent isotretinoin use, or pregnancy were not studied separately and cannot assume the same result. Atrophic scars are indented scars left after acne destroys collagen. Split-face means each participant received active treatment on one cheek and control on the other, so healing could be compared in the same person.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Who was studied

The trial enrolled adults with moderate-to-severe atrophic acne scars, according to Dermatology and Therapy via Springer in the trial report. One cheek received fractional microneedle radiofrequency plus transdermal PLLA. The other cheek received the same device plus sterile water. All participants had Fitzpatrick skin types III to V.

That range covers medium to brown skin that tans easily or is moderately pigmented. It does not include very fair type I to II skin or very dark type VI skin. The device was an EXION microneedle monopolar radiofrequency system used at 2.5-mm depth and 80 to 100 percent energy. Immediately after microneedling, clinicians applied 2.5 mL Sculptra PLLA suspension for delivery through the microchannels.

What recovery looked like

Recovery events were mild, transient and self-limiting, according to Dermatology and Therapy via Springer in the safety findings. After each session about 1 of 24 participants had mild redness that cleared within days to one month. Another participant had an acne flare that cleared within days. No severe or persistent safety problem was reported.

The pattern points to short downtime rather than lasting injury in the studied group. Redness and a brief breakout were the main issues to expect. For medium to brown skin, device choice matters for pigment risk. A comprehensive review found fractional microneedling radiofrequency had less downtime and post-inflammatory hyperpigmentation than fractional CO2 laser in darker skin shades, as reported by the U.S. National Library of Medicine/PMC in the Cureus 2024 review.

What this means for icepick scars

Icepick scars are narrow, deep pits about 0.5 to 1.5 mm wide. Boxcar scars are wider at 1.5 to 4 mm, and rolling scars are wider still at over 4 mm, as described by the U.S. National Library of Medicine/PMC in the scar classification review. The 2026 trial reported overall results for moderate-to-severe atrophic scars.

It did not report icepick-only clearance or icepick-specific pigment outcomes. A person with mostly deep icepick pits therefore has less direct evidence than the headline result suggests. Deep narrow pits often respond differently than broad rolling scars. Microneedle depth, energy, and drug delivery may not reach the base of every icepick tract the same way. Do not read an average scar-score gain as a promise for deep icepick lesions.

Who was not studied and what to do

Several groups were excluded and have no recovery or pigment data from this trial. They include people with active acne, keloid or thick-scar history, isotretinoin use within 6 months, pregnancy or lactation, and disorders that impair wound healing.

Check this list before assuming the same healing profile: Bring the list to a dermatologist and ask about alternatives, monitoring, and timing. A clinician can weigh punch techniques, laser options, chemical reconstruction, or waiting until acne, isotretinoin washout, or pregnancy issues resolve.

  • scars are mainly deep icepick lesions
  • active breakouts are present
  • personal history of keloids or hypertrophic scars
  • isotretinoin in the past 6 months
  • Fitzpatrick type I to II or type VI skin

You Might Also Like

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.